Torbay Pharma
Jeffrey Arthur has a background in biochemistry and has worked in various roles within the pharmaceutical and biotechnology industry. Jeffrey's experience includes technical transfer of processes, gene therapy manufacturing facility implementation, equipment and consumables management, and manufacturing of Coagulation factor medicines. Jeffrey has also worked in laboratory-based roles providing technical support in biological, chemical, physical, and life sciences. Jeffrey has a Bachelor of Science degree from The University of Huddersfield.
Torbay Pharma
Torbay Pharma is a licence holder and global specialist in the manufacture and supply of terminally sterilized injectables for the secondary care market. We work with generic pharmaceutical companies seeking to ensure their sterile injectable products get to market reliably and without delay. As a CMO and CDMO, we offer fill/finish services for terminally sterilised injectables into plastic and glass vials and ampoules. Our specialist portfolio includes licensed and unlicensed terminally sterilised injectables, electrolyte solutions for total parenteral nutrition (TPN) compounding and a range of non-sterile oral solutions. Established in the 1970s as part of the Torbay and Devon NHS Foundation Trust, we have grown into a 250-strong team operating from our purpose built manufacturing facility in Paignton, UK. November 2023 saw us receive investment from NorthEdge, we’re now Torbay Pharmaceuticals Ltd. Torbay Pharma offer niche product experience and capabilities, an agile approach and a team of experts who genuinely care. Our determination and flexibility at every step, ensure quality products are efficiently supplied to market, with clear communication and consultancy throughout the process. If you think we can help you with your next project, visit our website: www.torbaypharma.com